AGP Executive Report
Last update: 8 hours agoRSV Vaccines in Focus (EU procurement): The European Commission signed a joint contract to secure up to 24 million doses of Moderna’s mResvia for adults ahead of the 2026–2027 RSV season, with Luxembourg among the six requesting countries. Alzheimer’s Breakthrough (human biomarker signal): A Phase 2a oral drug targeting brain immune cells via the CB2 pathway has shown measurable anti-neuroinflammation biomarker changes in living Alzheimer’s patients, adding early human support for neuroinflammation-focused treatment. Online Safety for Kids (EU rules): An EU expert panel backed EU-wide restrictions for social media under-13s, pushing a “safe by design” approach that shifts proof onto platforms, with legislation expected after summer. Nutrition Label Debate (Nutri-Score pushback): Estonia’s pediatric group urges voluntary Nutri-Score front-of-pack labels, while industry associations argue for waiting for an EU-wide unified system. Public Health Alert (Luxembourg-linked recall): Germany’s Rewe ja! Frozen Berry Mix recall over hepatitis A contamination also reached Luxembourg; customers are urged not to eat the affected batch. Heat & Worker Safety (EU unions): Unions are pressing for binding EU heat protections, including the right to cancel work above 30°C, citing major heat stress risks for millions of workers. Local Health Education (first aid in schools): Luxembourg’s primary schools are expanding first-aid training so children can act in the first minutes before ambulances arrive.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
